John G. Shelton
- Co-authors
- James A. McCubreyLinda S. SteelmanRichard A. FranklinWilliam L. BlalockJohn Tayu LeeFumin ChangPatrick M. NavolanicMartin McMahon
- Topics
- PI3K/AKT/mTOR signaling in cancer (6 papers)Cytokine Signaling Pathways and Interactions (6 papers)Melanoma and MAPK Pathways (5 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
John G. Shelton
17 papers receiving 923 citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 638
- Oncology 267
- Pathology and Forensic Medicine 105
- Cancer Research 102
- Immunology 85
Countries citing papers authored by John G. Shelton
This map shows the geographic impact of John G. Shelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Shelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Shelton more than expected).
Fields of papers citing papers by John G. Shelton
This network shows the impact of papers produced by John G. Shelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Shelton. The network helps show where John G. Shelton may publish in the future.
Co-authorship network of co-authors of John G. Shelton
This figure shows the co-authorship network connecting the top 25 collaborators of John G. Shelton. A scholar is included among the top collaborators of John G. Shelton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Shelton. John G. Shelton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 103 | |
| 2 | 21 | |
| 3 | 33 | |
| 4 | 23 | |
| 5 | 9 | |
| 6 | 41 | |
| 7 | 13 | |
| 8 | 71 | |
| 9 | 12 | |
| 10 | 32 | |
| 11 | 29 | |
| 12 | 92 | |
| 13 | 15 | |
| 14 | 78 | |
| 15 | Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). | 332 |
| 16 | 20 | |
| 17 | 5 |
About John G. Shelton
John G. Shelton is a scholar working on Oncology, Genetics and Hematology, having authored 17 papers that have together received 929 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (6 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Melanoma and MAPK Pathways (5 papers). The work is most often cited by research in Oncology (267 citations), Molecular Biology (638 citations) and Cancer Research (102 citations). John G. Shelton has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include James A. McCubrey, Linda S. Steelman, Richard A. Franklin, William L. Blalock, John Tayu Lee, Fumin Chang, Patrick M. Navolanic, Martin McMahon, Everett C. Pesci and M. Worth Calfee. Their work appears in journals such as Cancer Research, Oncogene and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.